Outsmarting Osteosarcoma 2022

Outsmarting 2022 Award Programs

MIB Agents is now accepting applications for our 2022 Outsmarting Osteosarcoma grant cycle. We are thrilled to offer multiple awards this year in addition to introducing a new Young Investigator award.

The Outsmarting Osteosarcoma Research Award
$100,000 grant over one year to any investigator with a proven track record in osteosarcoma and a compelling study that will Make It Better for osteosarcoma patients.

The Outsmarting Osteosarcoma Young Investigator (YI) Research Award
$50,000 grant over one year to any young investigator with a promising and compelling study that will Make It Better for osteosarcoma patients.

Awards may be sponsored by one MIB Agents Family Fund or individual donor, which is co-branded in
honor of the Family Fund. Multiple grants will be awarded in 2022, and the number of grants by award type will be determined based on budget and program goals during programmatic review.

ABOUT THE OUTSMARTING OSTEOSARCOMA GRANT PROGRAM

$500,000 awarded to date
The OutSmarting Osteosarcoma Research Grant is an annual award begun in 2017. For the past five
years, $100,000 has been awarded each year to a project that will focus on moving research forward for
osteosarcoma patients.

Family Funds Supporting Science
Collaboration among the scientific and patient community is a key hallmark of MIB Agents. MIB Agents
Outsmarting Osteosarcoma grants are supported by MIB Agents Family Funds, osteosarcoma patients
and families who raise funds in honor of an OsteoWarrior or OsteoAngel. Their dedication to Making It
Better and fostering collaboration and education in the scientific community makes every MIB Agents
award incredibly meaningful.
‍
Our collaborative and robust review process
The two tier review process results in a robust and collaborative review process that uniquely
incorporates patient and family perspective.

Please email christina@mibagents.org with any questions.